EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV

Chen Wang, Zhi-Ying Li, Gui-Ping Jiang, Ming-Hui Zhao, Min Chen

Clinical and Experimental Medicine · 2024

DOI: 10.1007/s10238-024-01351-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Chen Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, No.8 Xishiku Street, Xicheng Dis…. Hauptthemen laut MEDLINE: COVID-19, Disease Progression, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Fund, China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To identify risk factors for COVID-19 infection and investigate the impact of COVID-19 infection on chronic kidney disease (CKD) progression and vasculitis flare in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). This cohort study retrospectively analyzed the prevalence and severity of COVID-19 infection in 276 patients with AAV who were followed up. Logistic regression was employed to estimate the risk of COVID-19 infection as well as CKD progression and vasculitis flare upon COVID-19 infection. During the 6-month observation period, 213 (77.2%) of 276 patients were diagnosed with COVID-19 infection. Of these 213 patients, 49 (23.0%) had a COVID-19-related inpatient admission, including 17 patients who died of COVID-19 infection. AAV patients with severe COVID-19 infection were more likely to be male (OR 1.921 [95% CI 1.020–3.619], P = 0.043), suffered from worse kidney function (serum creatinine [Scr], OR 1.901 [95% CI 1.345–2.687], P < 0.001), had higher C-reactive protein (CRP) (OR 1.054 [95% CI 1.010–1.101], P = 0.017) and less likely to have evidence of initial vaccination (OR 0.469 [95% CI 0.231–0.951], P = 0.036), and Scr and COVID-19 vaccination were proven to be significantly associated with severe COVID-19 infection even after multivariable adjustment. Severe COVID-19 infection was significantly associated with subsequent CKD progression (OR 7.929 [95% CI 2.030–30.961], P = 0.003) and vasculitis flare (OR 11.842 [95% CI 1.048–133.835], P = 0.046) among patients with AAV. AAV patients who were male, and with worse kidney function were more susceptible to severe COVID-19 infection, which subsequently increased the risk of CKD progression and vasculitis flare.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Disease ProgressionAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisRenal Insufficiency, ChronicSARS-CoV-2HumansMaleFemaleMiddle AgedRisk FactorsRetrospective StudiesAgedSeverity of Illness IndexAdult

Stichwörter der Autor:innen

ANCACOVID-19FlareVasculitis

Autor:innen und Institutionen

  • Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
  • Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
  • Renal Division, The People's Hospital of Rongchang District, Chongqing, China.
  • Peking-Tsinghua Center for Life Sciences, Beijing, China.
  • Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China. chenmin74@sina.com.

Förderung

  • National Natural Science Fund, China
  • National Key Research and Development Program of China

Zitieren

APA

Wang, C., Li, Z. Y., Jiang, G. P., Zhao, M. H., & Chen, M. (2024). Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01351-x

Vancouver

Wang C, Li ZY, Jiang GP, Zhao MH, Chen M. Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01351-x

BibTeX
@article{Wang2024,
  author = {Wang, Chen and Li, Zhi-Ying and Jiang, Gui-Ping and Zhao, Ming-Hui and Chen, Min},
  title = {Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  doi = {10.1007/s10238-024-01351-x}
}
Kostenlos starten →